ArticleBone marrow transplantation2017

Diffusing capacity impairment is prevalent in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.

J S Stenehjem et al.PubMed ↗Publisher ↗

No numbers read from the abstract.